Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA
about
A systematic review of individual patient data meta-analyses on surgical interventions.Third universal definition of myocardial infarction.Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions.Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.The histone H3K9 methyltransferase SUV39H links SIRT1 repression to myocardial infarction.Periprocedural myocardial enzyme elevation: prognostic implications for current practice.Prognostic relevance of PCI-related myocardial infarction.Timing of angiography in non-ST elevation myocardial infarction.The evolving role of cardiac troponin in the evaluation of cardiac disorders.High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.Universal MI definition update for cardiovascular disease.First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial.Predictors and clinical implication of high-sensitivity cardiac troponin-I elevation following diagnostic cardiac catheterisations.Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer.FAME 2: Reshaping the approach to patients with stable coronary artery disease.Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial.Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial bImpact on prognosis of periprocedural myocardial infarction after percutaneous coronary intervention.Third universal definition of myocardial infarction
P2860
Q30653434-9A62018E-C601-477B-8FB5-F3BF53634CDBQ34295914-A98707B3-8BF9-4D72-8EE2-93CF6859725CQ36377265-529B8050-5CDC-4B32-B067-F64AE5C2B880Q37472971-CDCD0A2E-0044-45A8-A77A-FEE6BC76C084Q37590053-8E2A4E74-58C5-4557-BC69-E29C4B2B922EQ37737903-9C6265D5-E519-4548-9C7F-B547975ED8B7Q38016744-24FEE367-9608-447D-BD84-3F43B8DA72BAQ38084414-A57B38CB-7C0C-4ED8-95A7-4E0DFC58AEB8Q38100602-767D4C61-FD80-4C9A-A9D8-E0975328FAE0Q38140759-6EC10DC8-399F-4596-9271-8F5ACEAAF5EFQ38165881-9A7DA808-F729-43D9-B513-DA474B6110B3Q38209902-8E6B00DC-303A-45F3-BA60-D84FE9CEBB6AQ38398602-D2660170-B052-4F26-ADB1-3363708ACE6BQ38648931-045ECF69-C624-4DEE-B524-60233740128EQ38683249-80535933-BA39-4A55-A2B1-F01D93983A66Q42223302-751CD722-8D5B-4CA0-8BB5-52B7841879A8Q45811402-993E9149-69E0-4CF7-8E79-D36265ADC8DDQ45839848-66DB9004-E2CD-41ED-997D-D0F2112FCBBDQ47723318-59A7D32D-0FCA-45A5-8FB0-831C418C39A3Q50864248-E883FB4F-87F3-4D04-9130-FF954F28CAB2Q55071502-7678299A-237F-41B1-B4EE-F61944D095E3Q57314061-89B0609D-B40D-48C5-9096-48E48C448804
P2860
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@ast
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@en
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@nl
type
label
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@ast
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@en
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@nl
prefLabel
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@ast
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@en
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@nl
P2093
P921
P1433
P1476
Long-term cardiovascular morta ...... the FRISC II, ICTUS, and RITA
@en
P2093
Alexander Hirsch
Bo Lagerqvist
Fons Windhausen
Jan G P Tijssen
Keith A A Fox
Peter Damman
Robbert J de Winter
Stuart J Pocock
Tim Clayton
P304
P356
10.1161/CIRCULATIONAHA.111.061663
P407
P577
2011-12-23T00:00:00Z